130 related articles for article (PubMed ID: 30372908)
1. Hepatoprotective effect of bisbenzylisoquinoline alkaloid tiliamosine from Tiliacora racemosa in high-fat diet/diethylnitrosamine-induced non-alcoholic steatohepatitis.
Sylvester Darvin S; Toppo E; Esakkimuthu S; Ajeesh Krishna TP; Ceasar SA; Stalin A; Balakrishna K; Muniappan N; Pazhanivel N; Mahaprabhu R; Paulraj MG; Pandikumar P; Ignacimuthu S; Al-Dhabi NA
Biomed Pharmacother; 2018 Dec; 108():963-973. PubMed ID: 30372908
[TBL] [Abstract][Full Text] [Related]
2. Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models.
Toppo E; Sylvester Darvin S; Esakkimuthu S; Buvanesvaragurunathan K; Ajeesh Krishna TP; Antony Caesar S; Stalin A; Balakrishna K; Pandikumar P; Ignacimuthu S; Al-Dhabi NA
Biomed Pharmacother; 2018 Nov; 107():979-988. PubMed ID: 30257410
[TBL] [Abstract][Full Text] [Related]
3. Antihyperlipidemic and hepatoprotective effects of Gardenin A in cellular and high fat diet fed rodent models.
Toppo E; Darvin SS; Esakkimuthu S; Stalin A; Balakrishna K; Sivasankaran K; Pandikumar P; Ignacimuthu S; Al-Dhabi NA
Chem Biol Interact; 2017 May; 269():9-17. PubMed ID: 28351695
[TBL] [Abstract][Full Text] [Related]
4. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
[TBL] [Abstract][Full Text] [Related]
5. Effect of two andrographolide derivatives on cellular and rodent models of non-alcoholic fatty liver disease.
Toppo E; Darvin SS; Esakkimuthu S; Nayak MK; Balakrishna K; Sivasankaran K; Pandikumar P; Ignacimuthu S; Al-Dhabi NA
Biomed Pharmacother; 2017 Nov; 95():402-411. PubMed ID: 28863380
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis.
Mohamed RH; Tarek M; Hamam GG; Ezzat SF
Eur J Pharmacol; 2019 Sep; 858():172469. PubMed ID: 31233751
[TBL] [Abstract][Full Text] [Related]
7. MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.
Jiang W; Liu J; Dai Y; Zhou N; Ji C; Li X
J Gastroenterol Hepatol; 2015 May; 30(5):933-43. PubMed ID: 25559563
[TBL] [Abstract][Full Text] [Related]
8. Effect of resveratrol on experimental non-alcoholic steatohepatitis.
Heebøll S; Thomsen KL; Clouston A; Sundelin EI; Radko Y; Christensen LP; Ramezani-Moghadam M; Kreutzfeldt M; Pedersen SB; Jessen N; Hebbard L; George J; Grønbæk H
Pharmacol Res; 2015; 95-96():34-41. PubMed ID: 25814186
[TBL] [Abstract][Full Text] [Related]
9. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
[TBL] [Abstract][Full Text] [Related]
13. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
14. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk.
El-Derany MO; El-Demerdash E
Biochem Pharmacol; 2020 Jul; 177():113942. PubMed ID: 32240652
[TBL] [Abstract][Full Text] [Related]
15. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
Jiang W; Guo MH; Hai X
World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
[TBL] [Abstract][Full Text] [Related]
17. Extract of Citrus maxima (pummelo) leaves improve hepatoprotective activity in Wistar rats submitted to the induction of non-alcoholic hepatic steatosis.
Feksa DL; Coelho RP; Aparecida da Costa Güllich A; Dal Ponte ES; da Costa Escobar Piccoli J; Manfredini V
Biomed Pharmacother; 2018 Feb; 98():338-346. PubMed ID: 29274591
[TBL] [Abstract][Full Text] [Related]
18. The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats.
Huang CZ; Tung YT; Hsia SM; Wu CH; Yen GC
Food Funct; 2017 Feb; 8(2):842-850. PubMed ID: 28128372
[TBL] [Abstract][Full Text] [Related]
19. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis.
Dey P; Kim JB; Chitchumroonchokchai C; Li J; Sasaki GY; Olmstead BD; Stock KL; Thomas-Ahner JM; Clinton SK; Bruno RS
Food Funct; 2019 Oct; 10(10):6351-6361. PubMed ID: 31503268
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
Orime K; Shirakawa J; Togashi Y; Tajima K; Inoue H; Nagashima Y; Terauchi Y
Eur J Pharmacol; 2016 Feb; 772():22-32. PubMed ID: 26724391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
